Anticancer Activity and Metabolic Pathways of Natural Products 2.0

Dear Colleagues,

Cancer is a multifactorial disease which is caused by uncontrolled cell growth and the development of metastatic characteristics. Many compounds derived from natural products have recently been used in remarkable advances in anticancer therapy. Natural-product-based anticancer medications are garnering a lot of interest as next-generation anticancer treatments since they have low toxicity to normal cells and only kill cancer cells. As an alternative cancer treatment strategy, natural compounds can have a wide range of effects on carcinogenesis, interact with anticancer medications, and protect normal tissues of the host organism from the deleterious effects of anticancer therapies. Additionally, natural products induce metabolic changes in cancer cells, such as an increase in reactive oxygen species (ROS) production, which can directly result in cancer cell death and improve the anticancer effect of other conventional cancer treatments.

We kindly invite researchers to submit original research articles as well as review articles on the subject covered in this Special Issue of Biomedicines, entitled " Anticancer Activity and Metabolic Pathways of Natural Products Plant-Derived Targeted Strategies in Cancer", which aims to address the following objectives:

• To investigate the molecular mechanisms of new anticancer medicines based on natural product;
• To explore natural substances (with defined molecular compound) which may improve conventional anticancer therapy efficacy and its metabolism;
• To compare the metabolic effects of natural compounds with anticancer properties on normal tissues and cancer cells.

Dr. Seungho Baek
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.